Honasa Consumer Acquires Majority Stake In Fluence Pharma For ₹135 Cr

by · Inc42

SUMMARY

  • Mamaearth parent Honasa Consumer’s board has approved a majority stake acquisition in nutraceuticals company Fluence Pharma
  • It will acquire 58% stake in the company worth ₹135 Cr from its existing shareholders
  • Further, the company plans on buying out the remainder 42% equity stake via secondary transactions in two tranches over the next 5-7 years